• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物反应伴嗜酸性粒细胞增多和全身症状(DRESS):一种多器官抗病毒 T 细胞反应。

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.

机构信息

INSERM U905, Rouen University Hospital, Rouen 76000, France.

出版信息

Sci Transl Med. 2010 Aug 25;2(46):46ra62. doi: 10.1126/scitranslmed.3001116.

DOI:10.1126/scitranslmed.3001116
PMID:20739682
Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe, drug-induced reaction that involves both the skin and the viscera. Evidence for reactivation of herpes family viruses has been seen in some DRESS patients. To understand the immunological components of DRESS and their relationship to viral reactivation, we prospectively assessed 40 patients exhibiting DRESS in response to carbamazepine, allopurinol, or sulfamethoxazole. Peripheral blood T lymphocytes from the patients were evaluated for phenotype, cytokine secretion, and repertoire of CD4+ and CD8+ and for viral reactivation. We found Epstein-Barr virus (EBV), human herpes virus 6 (HHV-6), or HHV-7 reactivation in 76% of the patients. In all patients, circulating CD8+ T lymphocytes were activated, exhibited increased cutaneous homing markers, and secreted large amounts of tumor necrosis factor-alpha and interferon-gamma. The production of these cytokines was particularly high in patients with the most severe visceral involvement. In addition, expanded populations of CD8+ T lymphocytes sharing the same T cell receptor repertoire were detected in the blood, skin, liver, and lungs of patients. Nearly half of these expanded blood CD8+ T lymphocytes specifically recognized one of several EBV epitopes. Finally, we found that the culprit drugs triggered the production of EBV in patients' EBV-transformed B lymphocytes. Thus, cutaneous and visceral symptoms of DRESS are mediated by activated CD8+ T lymphocytes, which are largely directed against herpes viruses such as EBV.

摘要

药物反应伴嗜酸性粒细胞增多和全身症状(DRESS)是一种严重的药物诱导反应,涉及皮肤和内脏。一些 DRESS 患者中已经观察到疱疹家族病毒重新激活的证据。为了了解 DRESS 的免疫成分及其与病毒重新激活的关系,我们前瞻性评估了 40 名因卡马西平、别嘌醇或磺胺甲恶唑而出现 DRESS 的患者。评估了患者外周血 T 淋巴细胞的表型、细胞因子分泌以及 CD4+和 CD8+的受体库,以检测病毒重新激活。我们发现 76%的患者存在 EBV、HHV-6 或 HHV-7 重新激活。在所有患者中,循环 CD8+T 淋巴细胞被激活,表现出增加的皮肤归巢标志物,并分泌大量肿瘤坏死因子-α和干扰素-γ。在内脏受累最严重的患者中,这些细胞因子的产生尤其高。此外,在患者的血液、皮肤、肝脏和肺部中检测到相同 T 细胞受体库的 CD8+T 淋巴细胞群体扩张。这些扩张的血液 CD8+T 淋巴细胞中有近一半特异性识别几种 EBV 表位之一。最后,我们发现,罪魁祸首药物触发了患者 EBV 转化 B 淋巴细胞中 EBV 的产生。因此,DRESS 的皮肤和内脏症状是由激活的 CD8+T 淋巴细胞介导的,这些淋巴细胞主要针对 EBV 等疱疹病毒。

相似文献

1
Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.药物反应伴嗜酸性粒细胞增多和全身症状(DRESS):一种多器官抗病毒 T 细胞反应。
Sci Transl Med. 2010 Aug 25;2(46):46ra62. doi: 10.1126/scitranslmed.3001116.
2
Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro.药物反应伴嗜酸性粒细胞增多和全身症状(DRESS)患者中阿莫西林诱导的病情加重:7 例报告,并证明阿莫西林在体外对人类疱疹病毒 6 复制有直接作用。
Eur J Dermatol. 2010 Jan-Feb;20(1):68-73. doi: 10.1684/ejd.2010.0821. Epub 2009 Oct 12.
3
Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.人类疱疹病毒6型感染与伴有嗜酸性粒细胞增多和全身症状的药物反应的关联。
Arch Dermatol. 2001 Mar;137(3):301-4.
4
Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.药物性超敏反应综合征中除人疱疹病毒6型(HHV - 6)以外的其他人类疱疹病毒(HHV)家族成员的再激活
Br J Dermatol. 2006 Aug;155(2):344-9. doi: 10.1111/j.1365-2133.2006.07332.x.
5
Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study.人类疱疹病毒激活与药物性皮肤不良反应患者细胞因子谱变化的前瞻性对比研究。
Allergy. 2015 May;70(5):568-75. doi: 10.1111/all.12602. Epub 2015 Mar 16.
6
Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.药物反应伴嗜酸性粒细胞增多和全身症状严重病例的十二年分析:不可预测的多器官功能衰竭的一个原因
Arch Dermatol. 2009 Jan;145(1):67-72. doi: 10.1001/archderm.145.1.67.
7
[Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation].[自身免疫性甲状腺炎与伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)及HHV-6病毒再激活相关]
Ann Dermatol Venereol. 2011 Aug-Sep;138(8-9):580-5. doi: 10.1016/j.annder.2011.01.048. Epub 2011 Mar 21.
8
Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.异基因造血干细胞移植中爱泼斯坦-巴尔病毒(EBV)再激活:病毒载量、EBV特异性T细胞重建与利妥昔单抗治疗之间的关系
Transplantation. 2004 Jan 15;77(1):76-84. doi: 10.1097/01.TP.0000093997.83754.2B.
9
Drug rash with eosinophilia and systemic symptoms (DRESS): changing carbamazepine to phenobarbital controlled epilepsy without the recurrence of DRESS.药物反应伴嗜酸性粒细胞增多和全身症状(DRESS):改用苯巴比妥控制癫痫,未再发 DRESS。
Eur J Dermatol. 2010 Mar-Apr;20(2):220-2. doi: 10.1684/ejd.2010.0887. Epub 2010 Jan 26.
10
T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.慢性活动性EB病毒感染中的T细胞库及EB病毒特异性T细胞反应:一项病例研究
Clin Immunol. 2006 Apr;119(1):79-86. doi: 10.1016/j.clim.2005.11.008. Epub 2006 Jan 4.

引用本文的文献

1
Carbamazepine-Induced DRESS Syndrome During Epstein-Barr Virus Reactivation in an Adolescent.青少年爱泼斯坦-巴尔病毒再激活期间卡马西平诱发的药物超敏反应伴嗜酸性粒细胞增多和系统症状综合征
J Pediatr Pharmacol Ther. 2025 Jun;30(3):372-375. doi: 10.5863/JPPT-24-00015. Epub 2025 Jun 9.
2
Lady in Red: A Fatal Case of Drug Reaction With Eosinophilia and Systemic Symptoms.《红衣女士:药物反应伴嗜酸性粒细胞增多和全身症状的致命病例》
Cureus. 2025 Apr 14;17(4):e82235. doi: 10.7759/cureus.82235. eCollection 2025 Apr.
3
Carbamazepine-Induced DRESS Complicated by HLH and VBDS: A Case Report.
卡马西平诱发的伴噬血细胞性淋巴组织细胞增生症和病毒相关性噬血细胞性淋巴组织细胞增生症的药物超敏反应综合征:一例报告
J Asthma Allergy. 2025 Apr 29;18:655-664. doi: 10.2147/JAA.S505666. eCollection 2025.
4
Refining cytokine-based diagnostics in DRESS: A two-color IFN-γ/IL-4 ELISpot approach.优化药物超敏反应综合征中基于细胞因子的诊断方法:一种双色 IFN-γ/IL-4 酶联免疫斑点法。
World Allergy Organ J. 2025 Apr 3;18(4):101049. doi: 10.1016/j.waojou.2025.101049. eCollection 2025 Apr.
5
Warren Alpert Medical School at Brown University: Clinicopathologic Conference: April 1st, 2022. Case 02-2022: A 66 Year-Old Male with Nausea, Vomiting, Fever and Rash.布朗大学沃伦·阿尔珀特医学院:临床病理讨论会:2022年4月1日。病例02 - 2022:一名66岁男性,伴有恶心、呕吐、发热和皮疹。
Brown J Hosp Med. 2022 May 16;1(2):35708. doi: 10.56305/001c.35708. eCollection 2022.
6
Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms With Reactivation of Human Herpesvirus-6 in a Liver Transplant Recipient.肝移植受者中药物诱导的超敏反应综合征/伴嗜酸性粒细胞增多和全身症状的药物反应与人疱疹病毒6型再激活
Transpl Infect Dis. 2025 May-Jun;27(3):e14447. doi: 10.1111/tid.14447. Epub 2025 Jan 30.
7
Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases.与嗜酸性粒细胞增多和全身症状的药物反应相关的致命结局:FAERS数据库的不成比例分析及病例系统评价
Front Immunol. 2024 Dec 16;15:1490334. doi: 10.3389/fimmu.2024.1490334. eCollection 2024.
8
Literature review of the clinical features of sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS).柳氮磺胺吡啶诱导的药物反应伴嗜酸性粒细胞增多和全身症状/药物性超敏反应综合征(DRESS/DIHS)临床特征的文献综述
Front Pharmacol. 2024 Dec 2;15:1488483. doi: 10.3389/fphar.2024.1488483. eCollection 2024.
9
A Rare Case of Vancomycin-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.1例罕见的万古霉素诱导的伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)综合征。
Cureus. 2024 Nov 5;16(11):e73088. doi: 10.7759/cureus.73088. eCollection 2024 Nov.
10
Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).药物反应伴嗜酸性粒细胞增多和全身性症状(DRESS)中的病毒再激活与临床结局。
Sci Rep. 2024 Nov 18;14(1):28492. doi: 10.1038/s41598-024-69054-7.